Archief Roodbont

What is most applicable to physicians is that there was an approximate 30% reduction in triglyceride levels among those treated with the omega-3 fatty acids," said Bays. "When we look at the LDL-cholesterol levels, there was no significant difference in the change in LDL cholesterol in this trial. There was a small median increase, which wasn't significant. The reason this is important is because we can now say that many patients who have persistent elevations in their triglyceride levels, even after they've been on stable statin therapy, can benefit from dietary supplementation. Adding the omega-3 fatty acid can lower triglycerides and lower non-HDL cholesterol, all without adversely affecting LDL levels."